Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Puttick

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
ACS Central Science|June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific AntibodiesZachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Cancers|December 20, 2018
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of GlioblastomaCarolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
PET Imaging Quantifying <sup>68</sup>Ga-PSMA-11 Uptake in Metastatic Colorectal CancerTahleesa J Cuda, Andrew D Riddell, Cheng Liu, et al.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Contrast Media & Molecular Imaging|October 8, 2021
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal CancerTahleesa J Cuda, Yaowu He, Thomas Kryza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Preclinical Evaluation of [<sup>212</sup>Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate CancerFeifei Liu, Melissa E Monterosso, Didier Boucher, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Theranostics|April 1, 2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaThomas Kryza, Tashbib Khan, Simon Puttick, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
ACS Central Science|June 4, 2020
Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific AntibodiesZachary H Houston, Jens Bunt, Kok-Siong Chen, et al.
Cancers|December 20, 2018
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of GlioblastomaCarolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
PET Imaging Quantifying <sup>68</sup>Ga-PSMA-11 Uptake in Metastatic Colorectal CancerTahleesa J Cuda, Andrew D Riddell, Cheng Liu, et al.
Theranostics|October 24, 2022
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapyTashbib Khan, Nicholas J Lyons, Madeline Gough, et al.
Contrast Media & Molecular Imaging|October 8, 2021
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal CancerTahleesa J Cuda, Yaowu He, Thomas Kryza, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Preclinical Evaluation of [<sup>212</sup>Pb]Pb-ADVC001: A Prostate-Specific Membrane Antigen-Targeted α-Therapy for Prostate CancerFeifei Liu, Melissa E Monterosso, Didier Boucher, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Theranostics|April 1, 2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaThomas Kryza, Tashbib Khan, Simon Puttick, et al.
Pageof 4